Skip to content
Screener

Entrada Therapeutics TRDA Q3 2025 earnings

Reported November 6, 2025 · Before market open

Revenue$1.6MMiss by $6.9M
EPS-$1.06Miss by $0.02
Revenue estimate$8.5M
EPS estimate-$1.04

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$2.1M
EPS estimate-$0.98

FAQ

When did Entrada Therapeutics report Q3 2025 earnings?
Entrada Therapeutics (TRDA) reported Q3 2025 earnings on November 6, 2025 before market open.
What were Entrada Therapeutics's Q3 2025 revenue and EPS?
Entrada Therapeutics reported revenue of $1.6M and eps of $-1.06 for Q3 2025.
Did Entrada Therapeutics beat estimates in Q3 2025?
Revenue missed the consensus estimate of $8.5M by $6.9M. EPS missed the consensus estimate of $-1.04 by $0.02.
How did Entrada Therapeutics's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 91.8% from $19.6M a year earlier and eps declined 202.9% from $-0.35.
Where can I find Entrada Therapeutics's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001689375-25-000049) and the 10-Q periodic report (0001689375-25-000050) directly on SEC EDGAR. The filing index links above go to sec.gov.